Lunit is a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, with a focus on conquering cancer through AI and setting new milestones for AI in cancer care.

Lunit Inc. develops and provides AI based software solutions for cancer screening/diagnosis and treatment. It offers AI solution for chest X-ray and mammography, as well as AI-powered biomarker for immune phenotyping and PD-L1 quantification for immunotherapy. The company was incorporated in 2013 and is based in Seoul, South Korea.

3281

IO:LUNIT

Lunit

Last Close

67,600.00

14/02 06:30

Market Cap

1.36T

Beta: -

Volume Today

615.83K

Avg: -

Analysis Not Available